|
|
|
|
|
|
|
Why Your Medtech RWD Strategy Will Fail In Latin America
|
|
By Julio G. Martinez-Clark, bioaccess
|
Regulators are actively encouraging medtech companies to use real-world data and synthetic control arms. Here's why this is currently incompatible with Latin America's fragmented RWD infrastructure, though this will change in the years ahead.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Med Device Online: |
|
|
|
|